Locus Biosciences Inc
Dba Locus Biosciences Inc
CAGE Code: 7H2T2
NCAGE Code: 7H2T2
Status: Active
Type: Commercial Supplier
Summary
Locus Biosciences Inc, Dba Locus Biosciences Inc is an Active Commercial Supplier with the Cage Code 7H2T2.
Address
523 Davis Dr
Ste 350
Morrisville NC 27560-7165
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Advanced Engineering And Research Dialog Llc General Felt Industries Penn Jersey Office Products Perfect Move Inc Software Seminars General Electric Medical Systems Educational Testing Service Cmc Maintenance Co Sie-Med Inc On Technology Corp Yardley Products Corp Sub Of Predco Computer Partners U S A Inc Farpoint Technologies Inc Wmk, Llc Octapus Technologies Snipes Farm And Nursery Chemcentral Philadelphia Netedge Systems Inc Intersolve Inc
Frequently Asked Questions (FAQ) for CAGE 7H2T2
- What is CAGE Code 7H2T2?
- 7H2T2 is the unique identifier used by NATO Organizations to reference the physical entity known as Locus Biosciences Inc Dba Locus Biosciences Inc located at 523 Davis Dr, Ste 350, Morrisville NC 27560-7165, United States.
- Who is CAGE Code 7H2T2?
- 7H2T2 refers to Locus Biosciences Inc Dba Locus Biosciences Inc located at 523 Davis Dr, Ste 350, Morrisville NC 27560-7165, United States.
- Where is CAGE Code 7H2T2 Located?
- CAGE Code 7H2T2 is located in Morrisville, NC, USA.
Contracting History for CAGE 7H2T2 Most Recent 25 Records
- 75A50120C00169
- Advance The Development Of Crphage As A Crispr-Engineered Precision Antibacterial Of Urinary Tract Infections Caused By E. Coli.
- 2 Nov 2021
- Advance The Development Of Crphage As A Crispr-Engineered Precision Antibacterial Of Urinary Tract Infections Caused By E. Coli.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $11,007,921.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00169
- Advance The Development Of Crphage As A Crispr-Engineered Precision Antibacterial Of Urinary Tract Infections Caused By E. Coli.
- 22 Jun 2022
- Advance The Development Of Crphage As A Crispr-Engineered Precision Antibacterial Of Urinary Tract Infections Caused By E. Coli.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $17,248,868.73
- Department Of Health And Human Services (Hhs)
- 75A50120C00169
- The Purpose Of This No Cost, Bilateral Modification Is To: A.) Update Article B.2, Base Period To Update The Pop Of Clin 0001. B.) The Period Of Performance For Clin 0001 (Base Period) Is Extended From 09/28/2020 - 09/27/2022 To 09/28/2020 - 03
- 27 Sep 2022
- The Purpose Of This No Cost, Bilateral Modification Is To: A.) Update Article B.2, Base Period To Update The Pop Of Clin 0001. B.) The Period Of Performance For Clin 0001 (Base Period) Is Extended From 09/28/2020 - 09/27/2022 To 09/28/2020 - 03
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $17,248,868.73
- Department Of Health And Human Services (Hhs)
- 75A50120C00169
- Advance The Development Of Crphage As A Crispr-Engineered Precision Antibacterial Of Urinary Tract Infections Caused By E. Coli.
- 9 Sep 2021
- Advance The Development Of Crphage As A Crispr-Engineered Precision Antibacterial Of Urinary Tract Infections Caused By E. Coli.
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $11,007,921.00
- Department Of Health And Human Services (Hhs)
- 75A50120C00169
- The Purposes Of This Bilateral Modification Are To: 1) Add $7,809,935.00 Under The Base Period Clin 0001 With A Period Of Performance Of September 28, 2022 ? March 31 2023; 2) Extend The Period Of Performance To September 20, 2024; 3) And Update
- 15 Feb 2023
- The Purposes Of This Bilateral Modification Are To: 1) Add $7,809,935.00 Under The Base Period Clin 0001 With A Period Of Performance Of September 28, 2022 ? March 31 2023; 2) Extend The Period Of Performance To September 20, 2024; 3) And Update
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $25,058,803.73
- Department Of Health And Human Services (Hhs)